The DOI matches its Crossref record; 68 of the 68 references it cites were found in a registry or an index.
Exosomes derived from mesenchymal stem cells repair a Parkinson’s disease model by inducing autophagy
Open accessAbstract
Parkinson’s disease (PD) is a progressively debilitating neurodegenerative condition that leads to motor and cognitive dysfunction. At present, clinical treatment can only improve symptoms, but cannot effectively protect dopaminergic neurons. Several reports have demonstrated that human umbilical cord mesenchymal stem cells (hucMSCs) afford neuroprotection, while their application is limited because of their uncontrollable differentiation and other reasons. Stem cells communicate with cells through secreted exosomes (Exos), the present study aimed to explore whether Exos secreted by hucMSCs could function instead of hucMSCs. hucMSCs were successfully isolated and characterized, and shown to contribute to 6-hydroxydopamine (6-OHDA)-stimulated SH-SY5Y cell proliferation; hucMSC-derived Exos were also involved in this process. The Exos were purified and identified, and then labeled with PKH 26, it was found that the Exos could be efficiently taken up by SH-SY5Y cells after 12 h of incubation. Pretreatment with Exos promoted 6-OHDA-stimulated SH-SY5Y cells to proliferate and inhibited apoptosis by inducing autophagy. Furthermore, Exos reached the substantia nigra through the blood–brain barrier (BBB) in vivo, relieved apomorphine-induced asymmetric rotation, reduced substantia nigra dopaminergic neuron loss and apoptosis, and upregulated the level of dopamine in the striatum. These results demonstrate that hucMSCs-Exos have a treatment capability for PD and can traverse the BBB, indicating their potential for the effective treatment of PD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures








Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“In the Parkinson’s disease rat model, isolated sEVs were injected into the tail vein. These sEVs, which were derived from hucMSCs, successfully pierced the BBB. As a result, the loss of dopaminergic neurons in the substantia nigra decreased significantly, whereas dopamine levels in the striatum increased. Moreover, the PD model rats exhibited improved behavioral function following sEVs injection”
From Extracellular vesicles as nanotheranostic platforms for targeted neurological disorder interventions (2024) · cites this paper as [256]
The cited source says what the claim attributes to it.
In the citing paper
“Importantly, it has been shown that human umbilical cord (hUC)-MSC-derived EVs pass the blood–brain barrier (BBB) and reach the midbrain substantia nigra.”
From Mesenchymal stem cell secretome for regenerative medicine: Where do we stand? (2025) · cites this paper as [238]
The cited source says what the claim attributes to it.
In the citing paper
“Once there, they were able to reduce dopaminergic neuron loss and improve behavioral deficits in the apomorphine-induced asymmetric rotation test in Parkinsońs disease rat models, suggesting the role of these EVs on dopaminergic neurons of the substantia nigra [238].”
From Mesenchymal stem cell secretome for regenerative medicine: Where do we stand? (2025) · cites this paper as [238]
In the citing paper
“The study results revealed a reduction of 6-OHDA-induced neuroinflammation in Parkinson’s disease [133].”
From Exosome for mRNA delivery: Strategies and therapeutic applications (2024) · cites this paper as [133]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Shedding light on the cell biology of extracellular vesicles
van Niel, G., D'Angelo, G., & Raposo, G. (2018) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm.2017.125 · Cited by 8,369
Membrane vesicles as conveyors of immune responses
Théry, C., Ostrowski, M., & Segura, E. (2009) · Nature Reviews Immunology · doi:10.1038/nri2567 · Cited by 3,882
Eaten alive: a history of macroautophagy
Yang, Z., & Klionsky, D. J. (2010) · Nature Cell Biology · doi:10.1038/ncb0910-814 · Cited by 2,095
Autophagy: from phenomenology to molecular understanding in less than a decade
Klionsky, D. J. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2245 · Cited by 1,934
Phinney, D. G., & Prockop, D. J. (2007) · Stem Cells · doi:10.1634/stemcells.2007-0637 · Cited by 1,908
Kim, J.-H., Auerbach, J. M., Rodríguez-Gómez, J. A., Velasco, I., Gavin, D., Lumelsky, N., Lee, S.-H., Nguyen, J., Sánchez-Pernaute, R., Bankiewicz, K., et al. (2002) · Nature · doi:10.1038/nature00900 · Cited by 1,607
Alzheimer's Disease and Parkinson's Disease
Nussbaum, R. L., & Ellis, C. E. (2003) · New England Journal of Medicine · doi:10.1056/nejm2003ra020003 · Cited by 1,351
Yamamoto, A., Tagawa, Y., Yoshimori, T., Moriyama, Y., Masaki, R., & Tashiro, Y. (1998) · Cell Structure and Function · doi:10.1247/csf.23.33 · Cited by 1,312
Autophagy and Neurodegeneration: Pathogenic Mechanisms and Therapeutic Opportunities
Menzies, F. M., Fleming, A., Caricasole, A., Bento, C. F., Andrews, S. P., Ashkenazi, A., Füllgrabe, J., Jackson, A., Jimenez Sanchez, M., Karabiyik, C., et al. (2017) · Neuron · doi:10.1016/j.neuron.2017.01.022 · Cited by 1,134
The Parkinson Pandemic—A Call to Action
Dorsey, E. R., & Bloem, B. R. (2018) · JAMA Neurology · doi:10.1001/jamaneurol.2017.3299 · Cited by 1,091
Cited by
Shetgaonkar, G. G., Marques, S. M., DCruz, C. E. M., Vibhavari, R. J. A., Kumar, L., & Shirodkar, R. K. (2021) · Drug Delivery and Translational Research · doi:10.1007/s13346-021-01026-0 · Cited by 400
“Therefore, the findings of this study indicated the prospects of these stem cell–derived exosomes for the efficacious therapy of Parkinson’s disease [133].”
BackgroundShao, J., Zaro, J., & Shen, Y. (2020) · International Journal of Nanomedicine · doi:10.2147/ijn.s281890 · Cited by 295
Mesenchymal stem cell secretome for regenerative medicine: Where do we stand?
Trigo, C. M., Rodrigues, J. S., Camões, S. P., Solá, S., & Miranda, J. P. (2025) · Journal of Advanced Research · doi:10.1016/j.jare.2024.05.004 · Cited by 252
“Once there, they were able to reduce dopaminergic neuron loss and improve behavioral deficits in the apomorphine-induced asymmetric rotation test in Parkinson´s disease rat models, suggesting the role of these EVs on dopaminergic neurons of the substantia nigra [238].”
Exosomes based strategies for brain drug delivery
Rehman, F. U., Liu, Y., Zheng, M., & Shi, B. (2023) · Biomaterials · doi:10.1016/j.biomaterials.2022.121949 · Cited by 229
Hua, T., Yang, M., Song, H., Kong, E., Deng, M., Li, Y., Li, J., Liu, Z., Fu, H., Wang, Y., et al. (2022) · Journal of Nanobiotechnology · doi:10.1186/s12951-022-01522-6 · Cited by 189
Metadata
- Authors
- Chen, H.-X., Liang, F.-C., Gu, P., Xu, B.-L., Xu, H.-J., Wang, W.-T., Hou, J.-Y., Xie, D.-X., Chai, X.-Q., & An, S.-J.
- Affiliations
- Hebei Medical University (CN)
- Hebei University of Chinese Medicine (CN)
- Second Hospital of Hebei Medical University (CN)
- Corresponding author
- Chai, Xi-Qing
- Venue
- Cell Death & Disease
- Published
- 2020-04-27
- Volume
- 11
- Issue
- 4
- Pages
- 288-288
- ISSN
- 2041-4889 (ISSN-L)
- PMC
- PMC7184757
- OpenAlex
- W3018217038
- Cited by
- 319
- References
- 68
- Citations by year
- 2026: 42 · 2025: 58 · 2024: 66 · 2023: 59 · 2022: 53 · 2021: 33 · 2020: 8
- FWCI
- 12.41
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
- Locations
- Cell Death and Disease (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- Natural Science Foundation of Hebei Province (18967728D)
- National Natural Science Foundation of China (81873230)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Extracellular vesicles in disease
- Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Mesenchymal stem cell research
- Keywords
- Parkinson's disease, exosomes, mesenchymal stem cells, human umbilical cord mesenchymal stem cells, autophagy, dopaminergic neuroprotection, 6-hydroxydopamine, SH-SY5Y cells, substantia nigra, blood-brain barrier, neuroprotection, apoptosis, dopamine
- MeSH terms
- Animals, Autophagy, Blood-Brain Barrier, Cell Differentiation, Humans, Parkinson Disease, Mice, Exosomes, Mesenchymal Stem Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Exosomes derived from mesenchymal stem cells repair a Parkinson’s disease model by inducing autophagy. https://app.cochat.ai/papers/10.1038/s41419-020-2473-5
- The paper
- Chen, H.-X., Liang, F.-C., Gu, P., Xu, B.-L., Xu, H.-J., Wang, W.-T., Hou, J.-Y., Xie, D.-X., Chai, X.-Q., & An, S.-J. (2020). Exosomes derived from mesenchymal stem cells repair a Parkinson’s disease model by inducing autophagy. Cell Death & Disease. https://doi.org/10.1038/s41419-020-2473-5
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.